CLINICAL_TRIALS
trial_result
· 2012-03-23
Clinical Trial Update: Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) [Phase 2]
Summary
Phase 2 trial of sunitinib malate in metastatic or surgically unresectable hepatocellular carcinoma was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Liver Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-03-23